Company Overview and News

58
Top 10 Of 53 Dividend Aristocrats Yield 3.4%-6.2% In July Update

2018-07-11 seekingalpha
The 53 Aristocrats stocks represent all 11 Morningstar sectors. Broker target top 10 net gains ranged from 12.8% to 20.6%.
APD XOM WBA KMB PEP JNJ CVX DOV ABBV CAH ED ABBV MCD

39
APD / Air Products & Chemicals, Inc. FORM 8-K (Current Report)

2018-06-28 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
APD

100
Stop Buying Commodities Funds

2018-06-19 seekingalpha
We’ve never been fans of direct commodities investments and have been warning about the lack of risk adjusted returns that commodities funds offer investors for years. In previous articles, we focused on the structural issues with commodities markets and commodities funds that make them unworthy of inclusion in investors’ portfolios. In this article, we want to focus on a different aspect of commodities funds that make them unattractive.
HAL RIO RIO BLT XOM APD PSX COP SHW RTPPF RTNTF VDE BHPBF VLO DWDP VALE PPG PX BHP RIO CVX DBC VAW BBL BHP PDBC SLB BHPLF AI

38
APD / Air Products & Chemicals, Inc. FORM SD

2018-05-31 sec.gov
Form SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
APD

39
APD / Air Products & Chemicals, Inc. FORM S-8

2018-05-18 sec.gov
Form S-8 As filed with the Securities and Exchange Commission on May 18, 2018 Registration No. 333-
APD

38
APD / Air Products & Chemicals, Inc. FORM 8-K (Current Report)

2018-05-17 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGT
APD

64
24 'Safer' Basic Materials 'WallStar' Dividends For May

2018-05-13 seekingalpha
24 of 45 Basic Materials top yield 'WallStar' stocks were tagged "safer" for dividends because they showed positive annual-returns, and free cash-flow yields greater than their dividend yields 5/10/18.
OLN APD SXCP WLK CBT LYB RGORF GOLD RRS DWDP GOLD ACIIQ MRI.U ACI MERC LALWF ARCH

63
'Safer' Dividend Champions Gains Led By Meredith, Leggett, Pepsi, Old Rep. And Walmart Per Broker May Targets

2018-05-11 seekingalpha
41 of 80 Dividend Champions (25 or more annual dividend hikes) were tagged 'safer' by showing positive annual returns, and free cash-flow yields greater than their dividend yields calculated 5/7/18.
APD O.PRF O MDP OPRF KMB NNN.PRD NNN.PRF NNN.PRE ERIE PEP JNJ CVX LEG MCD NNN ERIEB

38
Alternet Systems Pilot Production Of ReVolt Electric Motorcycle Ahead Of Schedule

2018-05-10 globenewswire
DALLAS, May 10, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Alternet Systems, Inc. (USOTC:ALYI) today announced the shipping of its first pilot production motorcycles is ahead of schedule. The company recently launched an Electric Vehicle (EV) business called ReVolt Electric Motorbikes utilizing the company’s portfolio of patented lithium battery technologies developed by Air Products and Chemicals, Inc.
ALYI APD

145
Top 'Safer' Dividend Aristocrats Are Leggett For Gains, And Procter & Gamble For Yield Per May Data

2018-05-04 seekingalpha
41 of 53 S&P 500 Dividend Aristocrats stocks were deemed "safer" for dividends because they showed positive one-year returns and free cash flow yields greater than their dividend yields 5/2/18.
LOW APD KMB PEP JNJ CINF CVX ITW DOV ABBV ABBV LEG MCD

126
Dividend Aristocrats Top Gainers: Leggett, Walgreens, AT&T, Nucor And Pepsi, Per Broker May Targets

2018-05-04 seekingalpha
"S&P 500® Dividend Aristocrats measure the performance S&P 500 companies that have increased dividends every year for the last 25 consecutive years."---us.spindices.com.
APD XOM WBA KMB NUE CTAS PEP JNJ CVX ABBV ED LEG ABBV

38
APD / Air Products & Chemicals, Inc. FORM 8-K (Current Report)

2018-04-26 sec.gov
Document UNITED STATES
APD

56
Chemical Stock Earnings Slated on Apr 26: APD, EMN & More

2018-04-25 zacks
A few prominent chemical companies are scheduled to report their quarterly numbers on Apr 26. The chemical industry is riding high on an upturn in the world economy and continued strength across major end-use markets such as construction, automotive and electronics. Another positive for the industry is a recovery in demand in the energy space – a key chemical end-market that had been out of favor for a spell.
APD TWX MS.PRE MS.PRF MS.PRG MS.PRA TWC EMN.WS MS.PRI PX EMN MS.PRK MS POL

417
Inflation And Trade War Are Triggering Declines - Cramer's Mad Money (4/19/18)

2018-04-20 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, April 19.
SQ PG APD AZO NXPI GOOG NUE AMZN PEP GOOGL AAPL URI MSFT ACIA QCOM

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

4h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

6h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to APD / Air Products & Chemicals, Inc. on message board site Silicon Investor.

APDR - Apollo Drilling, Inc.
CUSIP: 009158106